Skip to NavigationSkip to content

EMA discussing executive director post

Published on: 03/12/14

The European Medicines Agency has confirmed that Andreas Pott will remain in charge of the body in place of the ousted Guido Rasi as executive director, until the European Commission finalises his permanent replacement.

Pott (pictured) is stepping into Rasi’s shoes due to a judgment by the European Union Civil Service Tribunal that annulled his appointment as the agency’s executive director in November.

The European Commission now plans to publish a vacancy announcement for the post shortly, and the EMA board chaired by Sir Kent Woods has said that Pott will be in charge for the interim period.

The EMA says Sir Woods has been asked to explore how Guido Rasi can “best support the agency in the coming months as his contract is in operation”.

Rasi found himself at the centre of a legal wrangle after a former rival for the post complained to the European Union Civil Service Tribunal.

The tribunal ruled that the EC had not followed proper procedures during the recruitment of Rasi, who was appointed in October 2011 – and since the EC’s decision has been annulled, the EMA’s decision to appoint Rasi went the same way.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches